1Steinhubl SR, Moliterno DJ. The role of the platelet in the pathogenesis of atherothronabosis [J]. Am J Cardiovasc Drugs, 2005, 5(6): 399-408.
2Furie B, Furie BC. Mechanisms of thrombus formation[J]. N Engl J Med, 2008, 359(9): 938-949.
3Frossard M, Fuchs I, Leitner JM, et al. Platelet function pre- dicts myocardial damage in patients with acute myocardial in- farction[J]. Circulation, 2004, 110( 11 ) : 1392-1397.
4Steinhubl SR, Talley JD, Braden GA, et al. Point-of-caremea- sured platelet inhibition correlates with a reduced risk of an ad- verse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-AssessingUltegra) multicenter study[J]. Circulation, 2001, 103(21): 2572-2578.
6Clinical and Laboratory Standards Institute. EPSA-2 evaluation of preision performance of quantitative measurent method-approved guideline[M]. 2nd ed. USA: Clinical and Laboratory Standards Institute, 2004: 190.
7Ichihara K, ltoh Y, Lam CW, et al. Sources of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals [J]. Clin Chem, 2008, 54: 356-365.
二级参考文献6
1冯仁丰，主编，临床检验质量管理技术基础[M]．上海：上海科学技术文献出版社，2004．243．
2ISO15189:2003(E).医学实验室-质量和能力的专用要求[S].
3National Committee for Clinical Laboratory standards. How to Define and Reference Intervals in the Clinical Laboratory [ S ]. Wayne, PA : C28-A2, NCCLS,2000.
4Sinton TJ, Cowley DM, Bryant SJ. Reference interval for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles [J]. Clin Chem, 1986,32(1Pt 1):76-79.
5Solberg HE, Stamm D. International Federation of Clinical Chemistry IFCC. IFCC recommendation-theory of reference values. Part 4. Control of analytical variation in the production, transfer and application of reverence values [ J ]. Clin Chim Acta, 1991,202 ( 1-2 ) : S5-S11.
